Building the Right E-Health Partnerships in Obesity Care
About this Meeting
As obesity care continues to evolve, e-health partners are playing a growing role in how people are supported across activation, access and ongoing care. For pharma, this creates important strategic questions around which partners to prioritize, how to navigate a consolidating market, and what long-term value creation should look like.
Co-hosted by HLTH and Novo Nordisk, this private roundtable will bring together senior leaders from across Life Sciences and Health Tech to explore how partnership models in obesity care are changing. The discussion will examine what makes a strong e-health partner, how to think about retention and engagement over time, and how pharma companies can prepare for an increasingly consolidated e-health landscape.
Designed for senior decision-makers, this session offers a confidential forum to exchange insights, challenge assumptions, and shape the future of the obesity care ecosystem.
Join to discuss:
How is the concept of sustainable customer acquisition evolving in obesity care, and what role can partnerships play in shaping this?
How might pharma companies think about and prepare for a changing and potentially consolidating e-health landscape?
What approaches can support stronger long-term patient engagement and retention in obesity care?
How can partnerships between pharma and e-health providers create more durable value over time?
By applying to this event, you agree to our Terms and Privacy Notice.